H&P/Triad Stops OTC Manufacturing In Consent Decree With FDA
This article was originally published in The Tan Sheet
Executive Summary
FDA forbids Triad Group, H&P Industries and three employees from manufacturing or distributing OTC products until they comply with good manufacturing practices.
You may also be interested in...
People In Brief
CHPA scientists Schneider, Roehrig exit
Enforcement In Brief
Exec charged in bird flu claim case
Better Intra-Agency Reviews Could Speed FDA Seizure, Injunction Decisions
FDA is working to expedite its decision-making process for seizures and injunctions, which could translate into quicker enforcement actions for violative products.